Hundreds of patients in the U.S. are affected by myelofibrosis, or MF, each year.
http://www.fool.com/investing/general/2013/10/01/incyte-has-first-mover-advantage.aspx
http://www.fool.com/investing/general/2013/10/01/incyte-has-first-mover-advantage.aspx
No comments:
Post a Comment